Status: current, Defined. Date: 31-Jan 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4519241000168119 | Kabiven G19% (alanine 12 g / 2.566 L + arginine 8.5 g / 2.566 L + aspartic acid 2.6 g / 2.566 L + calcium chloride dihydrate 740 mg / 2.566 L + glutamic acid 4.2 g / 2.566 L + glycine 5.9 g / 2.566 L + histidine 5.1 g / 2.566 L + isoleucine 4.2 g / 2.566 L + leucine 5.9 g / 2.566 L + lysine hydrochloride 8.5 g / 2.566 L + magnesium sulfate heptahydrate 2.5 g / 2.566 L + methionine 4.2 g / 2.566 L + phenylalanine 5.9 g / 2.566 L + potassium chloride 4.5 g / 2.566 L + proline 5.1 g / 2.566 L + serine 3.4 g / 2.566 L + sodium acetate trihydrate 6.1 g / 2.566 L + sodium glycerophosphate 3.8 g / 2.566 L + threonine 4.2 g / 2.566 L + tryptophan 1.4 g / 2.566 L + tyrosine 170 mg / 2.566 L + valine 5.5 g / 2.566 L) injection [1 x 750 mL chamber] (&) (glucose 250 g / 2.566 L) injection [1 x 1.316 L chamber] (&) (soya oil 100 g / 2.566 L) injection [1 x 500 mL chamber], 3 x 2.566 L multi-chamber bags (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4519251000168117 | Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 3 x 2.566 L multi-chamber bags | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 3 x 2.566 L multi-chamber bags | Is a | Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 3 x 2.566 L multi-chamber bags | true | Inferred relationship | Some | ||
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 3 x 2.566 L multi-chamber bags | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 3 x 2.566 L multi-chamber bags | has container type | multi-chamber bag | true | Inferred relationship | Some | ||
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 3 x 2.566 L multi-chamber bags | has TP | Kabiven G19% | true | Inferred relationship | Some | ||
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 3 x 2.566 L multi-chamber bags | has TPUU | Kabiven G19% Glucose 250 g/2.566 L injection, 1.316 L chamber | true | Inferred relationship | Some | 935709883 | |
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 3 x 2.566 L multi-chamber bags | has subpack | Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 2.566 L multi-chamber bag | true | Inferred relationship | Some | 513222755 | |
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 3 x 2.566 L multi-chamber bags | has TPUU | Kabiven G19% Intralipid 100 g/2.566 L injection, 500 mL chamber | true | Inferred relationship | Some | 1695068408 | |
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 3 x 2.566 L multi-chamber bags | has TPUU | Kabiven G19% Vamin 18 Novum injection, 750 mL chamber | true | Inferred relationship | Some | 1803817822 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR